Capital expenditures are forecast to be between $90M-$105M and free cash flow conversion is expected to be between 95%-105%. For the full year, Donaldson anticipates repurchasing approximately 2% of its shares outstanding.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCI:
- DCI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Donaldson raises quarterly cash dividend 8% to 27c per share
- Donaldson, PolyPeptide to partner in peptide purification
- Donaldson to acquire 49% stake in Medica, terms undisclosed
- Donaldson price target raised to $62 from $59 at Morgan Stanley